BNIP3L
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like
Also known as: BNI3L_HUMAN, BNIP3a, Nix
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60238
- Gene
- BNIP3L
- Ensembl
- ENSG00000104765
- Chromosome
- 8
- Canonical length
- 219 aa
- Protein class
- Cancer-related genes, Predicted membrane proteins, Transporters
- Subcellular location
- Nuclear speckles,Mitochondria
OverviewNCBI Gene
This gene encodes a protein that belongs to the pro-apoptotic subfamily within the Bcl-2 family of proteins. The encoded protein binds to Bcl-2 and possesses the BH3 domain. The protein directly targets mitochondria and causes apoptotic changes, including loss of membrane potential and the release of cytochrome c. [provided by RefSeq, Feb 2015]
Canonical amino-acid sequenceUniProt
219 residues, UniProt reviewed canonical sequence.
>O60238|BNIP3L
1 MSSHLVEPPP PLHNNNNNCE ENEQSLPPPA GLNSSWVELP MNSSNGNDNG NGKNGGLEHV
61 PSSSSIHNGD MEKILLDAQH ESGQSSSRGS SHCDSPSPQE DGQIMFDVEM HTSRDHSSQS
121 EEEVVEGEKE VEALKKSADW VSDWSSRPEN IPPKEFHFRH PKRSVSLSMR KSGAMKKGGI
181 FSAEFLKVFI PSLFLSHVLA LGLGIYIGKR LSTPSASTYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BNIP3L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 182 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 182 nTPM
- retina: 136 nTPM
- adipose tissue: 122 nTPM
- ovary: 119 nTPM
- placenta: 98 nTPM
- blood vessel: 80 nTPM
Single-cell type
- esophageal apical cells: 916 nCPM
- endometrial glandular cells: 868 nCPM
- erythrocytes: 671 nCPM
- müller glia: 473 nCPM
- monocytes: 464 nCPM
- neutrophils: 452 nCPM
Immune cell
- neutrophil: 371 nTPM
- basophil: 337 nTPM
- classical monocyte: 299 nTPM
- total PBMC: 239 nTPM
- eosinophil: 184 nTPM
- myeloid DC: 167 nTPM
Brain region
- white matter: 170 nTPM
- medulla oblongata: 137 nTPM
- basal ganglia: 129 nTPM
- cerebellum: 122 nTPM
- midbrain: 120 nTPM
- cerebral cortex: 118 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.76
- gnomAD pLI
- 0.15
- gnomAD missense Z
- 1.18
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to hypoxia
- defense response to virus
- mitochondrial outer membrane permeabilization
- mitochondrial protein catabolic process
- negative regulation of apoptotic process
- negative regulation of mitochondrial membrane potential
- negative regulation of programmed cell death
- positive regulation of apoptotic process
- positive regulation of macroautophagy
- regulation of mitophagy
- regulation of programmed cell death
- regulation of protein targeting to mitochondrion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BNIP3L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BNIP3L as an antibody target. Whether an autoantibody or antibody against BNIP3L could matter depends on whether native BNIP3L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BNIP3L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BNIP3L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...